Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Lee, Jaecheol ^a   Kim, Youngkyun ^b   Yi, Hyoju ^b   Diecke, Sebastian ^a   Kim, Juryun ^b   Jung, Hyerin ^b   Rim, Yeri A ^b   Jung, Seung M ^b   Kim, Myungshin ^c   Kim, Yong G ^c   Park, Sung Hwan ^b   Kim, Ho Youn ^b   Ju, Ji H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; FIBROBLAST; GENETIC TRANSDUCTION; HUMAN; MOUSE; NUCLEAR REPROGRAMMING; OSTEOARTHRITIS; PHYSIOLOGY; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, SCID; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TRANSDUCTION, GENETIC;

EID: 84893178514     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4470     Document Type: Article

References (29)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
2. Puri MC, Nagy A. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells 2012, 30:10-14. 10.1002/stem.788, 22102565.
3. Bilic J, Izpisua Belmonte JC. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?. Stem Cells 2012, 30:33-41. 10.1002/stem.700, 22213481.
4. Tiscornia G, Vivas EL, Izpisúa Belmonte JC. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 2011, 17:1570-1576.
5. Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011, 10:915-929.
6. Estes BT, Diekman BO, Gimble JM, Guilak F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010, 5:1294-1311. 10.1038/nprot.2010.81, 3219531, 20595958.
7. Choi KD, Vodyanik M, Slukvin II. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc 2011, 6:296-313. 10.1038/nprot.2010.184, 3066067, 21372811.
8. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305. 10.1038/nature10761, 3652331, 22258608.
9. Oh Y, Wei H, Ma D, Liew R. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 2012, 98:443-449. 10.1136/heartjnl-2011-301317, 3285138, 22285968.
10. Onder TT, Daley GQ. New lessons learned from disease modeling with induced pluripotent stem cells. Curr Opin Genet Dev 2012, 22:500-508. 10.1016/j.gde.2012.05.005, 3489983, 22749051.
11. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 2006, 97:84-97. 10.1002/jcb.20546, 16088956.
12. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005, 52:2521-2529. 10.1002/art.21212, 16052568.
13. Kim MJ, Son MJ, Son MY, Seol B, Kim J, Park J, Kim JH, Kim YH, Park SA, Lee CH, Lee KS, Han YM, Chang JS, Cho YS. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum 2011, 63:3010-3021. 10.1002/art.30488, 21953087.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
15. Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KH, Chou SJ, Chang YL, Chang CM, Chen SJ, Ku HH, Li HY. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 2010, 19:247-258. 10.1089/scd.2009.0186, 19656070.
16. Hegen M, Keith JC, Collins M, Nickerson-Nutter CL. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008, 67:1505-1515. 10.1136/ard.2007.076430, 18055474.
17. Vierboom MP, Jonker M, Tak PP, 't Hart AB. Preclinical models of arthritic disease in non-human primates. Drug Discov Today 2007, 12:327-335. 10.1016/j.drudis.2007.02.012, 17395093.
18. Roep BO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci 2007, 1103:1-10. 10.1196/annals.1394.018, 17376838.
19. Lorenzo IM, Fleischer A, Bachiller D. Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells. Stem Cell Rev 2013, 9:435-450. 10.1007/s12015-012-9412-5, 23104133.
20. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 2009, 106:15768-15773. 10.1073/pnas.0906894106, 2735559, 19720998.
21. Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther 2011, 2:48. 10.1186/scrt89, 3340557, 22142803.
22. Tan KY, Eminli S, Hettmer S, Hochedlinger K, Wagers AJ. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One 2011, 6:e26406. 10.1371/journal.pone.0026406, 3196574, 22028872.
23. Zhou J, Wang X, Zhang S, Gu Y, Yu L, Wu J, Gao T, Chen F. Generation and characterization of human cryptorchid-specific induced pluripotent stem cells from urine. Stem Cells Dev 2013, 22:717-725. 10.1089/scd.2012.0260, 23025704.
24. El-Gabalawy H. The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol 2009, 23:49-58. 10.1016/j.berh.2008.11.004, 19233045.
25. Arend WP, Firestein GS. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 2012, 8:573-586. 10.1038/nrrheum.2012.134, 22907289.
26. Zimmermann A, Preynat-Seauve O, Tiercy JM, Krause KH, Villard J. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev 2012, 21:2364-2373. 10.1089/scd.2012.0088, 22559254.
27. Rao MS, Malik N. Assessing iPSC reprogramming methods for their suitability in translational medicine. J Cell Biochem 2012, 113:3061-3068. 10.1002/jcb.24183, 3552293, 22573568.
28. Ho PJ, Yen ML, Lin JD, Chen LS, Hu HI, Yeh CK, Peng CY, Lin CY, Yet SF, Yen BL. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2 - brief report. Arterioscler Thromb Vasc Biol 2010, 30:1905-1907. 10.1161/ATVBAHA.110.206540, 20689077.
29. Sohn YD, Han JW, Yoon YS. Generation of induced pluripotent stem cells from somatic cells. Prog Mol Biol Transl Sci 2012, 111:1-26.